Abstract
Through a global commercial collaboration, BD will help address the global threat of antimicrobial resistance. Through a worldwide commercial collaboration, BD will offer Accelerate's rapid testing solution for antibiotic resistance and susceptibility offering results in hours, versus one to two days as is the case with some traditional laboratory methods. Through a global commercial collaboration, BD will help address the global threat of antimicrobial resistance. Through a worldwide commercial collaboration, BD will offer Accelerate's rapid testing solution for antibiotic resistance and susceptibility offering results in hours, versus one to two days as is the case with some traditional laboratory methods.
Key Data
-
Publication Date18 August 2022
-
Primary AuthorAmanda Pedersen
-
SourceMD+DI
-
LanguageEnglish
Click below to visit original source: